To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Natural killer T (NKT) ly… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Natural killer T (NKT) lymphocytes regulate of intestinal tumor immunity

Doctoral thesis
Authors Ying Wang
Date of public defense 2017-09-22
ISBN 978-91-629-0272-8 (PRINT)
Publication year 2017
Published at Institute of Biomedicine, Department of Microbiology and Immunology
Language en
Links hdl.handle.net/2077/52418
Keywords NKT lymphocyte, intestinal tumor, CD1d, colrectal cancer, immunoregulation, α-gagactosylceramide
Subject categories Cancer and Oncology

Abstract

CD1d-restricted natural killer T (NKT) lymphocytes are known as potent early regulatory cells of immune responses, acting as a bridge between innate and adaptive immunity. While invariant NKT (iNKT) cells have a protective role in many tumor models, their ability to promote intestinal inflammation, known to enhance intestinal cancer, raised the question if they would be protective in intestinal tumor development. In this thesis we aimed to define the regulatory role of iNKT lymphocytes in the immune response to intestinal tumors, and explore iNKT cell directed immunotherapy in this disease. In the first section we have investigated the natural regulation by iNKT cells of intestinal tumor formation. ApcMin/+ mice were used as a mouse model for colorectal cancer (CRC) in these studies. By crossing ApcMin/+ mice with two different iNKT cell deficient mouse strains, we demonstrated that the absence of iNKT cells markedly decreased the total number of intestinal polyps in ApcMin/+ mice. Results from mechanistic studies suggest that iNKT cells promote intestinal polyps by enhancing the activity of regulatory T cells specifically in polyps, promoting a switch to a suppressive (M2) macrophage phenotype, and suppressing antitumor TH1 immunity. In the second section we performed preclinical therapeutic studies with different iNKT cell ligands to determine whether this treatment could subvert the tumor enhancing function of iNKT cells and result in suppressed tumor development. We demonstrate that iNKT cell directed immunotherapy prevented the tumor enhancing function of NKT cells leading to a reduction of tumor growth. Further, a treatment combining the iNKT ligand α-GalCer with PD-1/PD-L1/2 immune checkpoint blockade succeeded to further reduce polyp development. In summary, this thesis demonstrates that iNKT cells naturally promote intestinal tumor development, by enhancing immunoregulation and suppressing TH1 anti-tumor immunity. In contrast, iNKT cell directed immunotherapy combined with immune checkpoint blockade led to a reduction of tumors. This prompts further exploration of iNKT cell directed immunotherapy in intestinal cancer.

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?